NASDAQ:DMAC | Profit Breakdown | DiaMedica Therapeutics Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$10.5M-$10.13M-$10.14M
2026-03-31-$10.48M-$10.04M-$10.04M
2025-12-31-$9.21M-$8.73M-$8.74M
2025-09-30-$9.03M-$8.61M-$8.62M
2025-06-30-$8.01M-$7.69M-$7.7M
2025-03-31-$8.14M-$7.7M-$7.71M
2024-12-31-$8.42M-$7.89M-$7.9M
2024-09-30-$6.88M-$6.27M-$6.27M
2024-06-30-$5.64M-$5.11M-$5.12M
2024-03-31-$5.74M-$5.14M-$5.15M
2023-12-31-$5.85M-$5.14M-$5.16M
2023-09-30-$5.16M-$4.46M-$4.47M
2023-06-30-$4.74M-$4.47M-$4.48M
2023-03-31-$5.52M-$5.27M-$5.27M
2022-12-31-$3.97M-$3.74M-$3.75M
2022-09-30-$3.13M-$3.05M-$3.06M
2022-06-30-$3.36M-$3.35M-$3.36M
2022-03-31-$3.54M-$3.5M-$3.51M
2021-12-31-$3.25M-$3.24M-$3.25M
2021-09-30-$3.42M-$3.44M-$3.45M
2021-06-30-$3.37M-$3.27M-$3.27M
2021-03-31-$3.62M-$3.62M-$3.62M
2020-12-31-$4.27M-$4.19M-$4.2M
2020-09-30-$3.32M-$3.19M-$3.19M
2020-06-30-$2.71M-$2.47M-$2.47M
2020-03-31-$2.4M-$2.42M-$2.43M
2019-12-31-$2.77M-$2.48M-$2.48M
2019-09-30-$2.66M-$2.44M-$2.45M
2019-06-30-$2.74M-$2.46M-$2.47M
2019-03-31-$3.42M-$3.24M-$3.25M
2018-12-31$0.00-$2.12M-$1.96M-$1.96M
2018-09-30$500,000.00-$1.49M-$1.33M-$1.39M
2018-06-30-$1.85M-$1.72M-$1.74M
2018-03-31-$1.31M-$649,000.00-$650,000.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$34.4M-$32.74M-$32.77M
2024-12-31-$26.68M-$24.41M-$24.44M
2023-12-31-$21.27M-$19.34M-$19.38M
2022-12-31-$14M-$13.65M-$13.68M
2021-12-31-$13.65M-$13.56M-$13.59M
2020-12-31-$12.7M-$12.27M-$12.29M
2019-12-31-$11.59M-$10.62M-$10.65M
2018-12-31$500,000.00-$6.76M-$5.65M-$5.73M
2017-12-31-$4.52M-$4.26M-$4.26M